WHITEHAWK THERAPEUTICS INC
WHWKNASDAQ🏆 #3655 by market capEarnings Nov 4US Equity
$3.30▼ $0.16 (−4.62%)
Market closed · at closeTrack WHWK
Get earnings, price moves & breaking news on Telegram
24h▼ 4.6%
7d▲ 3.0%
14d▲ 15.0%
30d▼ 12.0%
ytd▲ 36.1%
1y▲ 48.6%
🏦Market Cap
$188M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
88.7%
High
💵FCF Margin
—
⚖️P/S Ratio
6.7x
Fair
Otter Score
—
Insufficient data
Trading Snapshot
- Day Range
- $3.25 – $3.51
- 52-Week Range
- $1.97 – $5.50
- Volume (shares)
- 33,157
- Avg Volume (shares)
- —
- Shares Outstanding
- 57.0M
- Next Earnings
- 2026-11-04
Fundamentals Snapshot
- Annual Revenue
- $7M
- Last Q Revenue
- —
- P/E Ratio
- —
- P/S Ratio
- 6.7x
- EPS (TTM)
- $-3.03
- Dividend Yield
- —
WHITEHAWK THERAPEUTICS INC
WHWKFinancial Trends
Financial history unavailable.
StockOtter · stockotter.spaceAbout WHITEHAWK THERAPEUTICS INC
Whitehawk Therapeutics Inc. is a biopharmaceutical enterprise currently undergoing clinical trials. This company specializes in crafting highly targeted treatment options for cancers that are identified by distinct genetic profiles.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
💎Quality★★★★★
⚖️Valuation★★★★★
Overall Score
Insufficient data
—/100
Analyst Ratings
ⓘConsensus
Buy
15 analysts
Strong Buy5
Buy6
Hold4
Sell0
Strong Sell0
Ratings as of Oct 2026
Latest News & Updates
News unavailable.